Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines

<p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties....

Full description

Bibliographic Details
Main Authors: Vannini Ivan, Medri Laura, Fabbri Francesco, Ulivi Paola, Rosetti Marco, Tesei Anna, Bolla Manlio, Amadori Dino, Zoli Wainer
Format: Article
Language:English
Published: BMC 2007-10-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/5/1/52
id doaj-ebb321b8ad544f0f84e6b7e63a726ad4
record_format Article
spelling doaj-ebb321b8ad544f0f84e6b7e63a726ad42020-11-24T20:51:29ZengBMCJournal of Translational Medicine1479-58762007-10-01515210.1186/1479-5876-5-52Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesVannini IvanMedri LauraFabbri FrancescoUlivi PaolaRosetti MarcoTesei AnnaBolla ManlioAmadori DinoZoli Wainer<p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties. In the present study, we investigated the mechanisms underlying the cytotoxicity of NCX 4040, a novel NO-aspirin with promising antineoplastic action, in <it>in vitro </it>human colon cancer models.</p> <p>Methods</p> <p>The effect on tumor growth was evaluated in four human colon cancer cell lines (LoVo, LRWZ, WiDr and LoVo Dx) by sulforhodamine B assay, oxidative stress by immunohistochemistry, apoptosis by laddering assay, mitochondrial membrane potential (ΔΨ<sub>m</sub>) by flow cytometry, and apoptosis- and chemoresistance-related markers by western-blot and real-time method, respectively. Prostaglandin E<sub>2 </sub>levels were determined by ELISA.</p> <p>Results</p> <p>NCX 4040 produced a higher cytotoxic effect in all the cell lines than that produced by other NO donors tested. In particular, in LoVo and LRWZ cells, NCX 4040 induced a cytocidal effect and apoptosis through p53 and NAG-1 expression, an early ΔΨ<sub>m </sub>collapse, and a sequential release of cytoplasmatic cytochrome c and caspase -9 and -3 active forms. 8-hydroxyguanine lesions, indicative of oxidative stress, were also observed. Conversely, in WiDr line, the drug caused a cytocidal effect, albeit not through apoptosis, and a concomitant increase in COX-2 activity. In LoVo Dx line, characterized by high levels drug resistance and DNA repair-related markers, only a cytostatic effect was observed, again in concomitance with the increase in COX-2 enzyme activity.</p> <p>Conclusion</p> <p>This study highlights the multiplicity of mechanisms involved in sensitivity or resistance to NCX 4040 and could provide useful indications for tailored therapy by identifying potentially drug-responsive tumors.</p> http://www.translational-medicine.com/content/5/1/52
collection DOAJ
language English
format Article
sources DOAJ
author Vannini Ivan
Medri Laura
Fabbri Francesco
Ulivi Paola
Rosetti Marco
Tesei Anna
Bolla Manlio
Amadori Dino
Zoli Wainer
spellingShingle Vannini Ivan
Medri Laura
Fabbri Francesco
Ulivi Paola
Rosetti Marco
Tesei Anna
Bolla Manlio
Amadori Dino
Zoli Wainer
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
Journal of Translational Medicine
author_facet Vannini Ivan
Medri Laura
Fabbri Francesco
Ulivi Paola
Rosetti Marco
Tesei Anna
Bolla Manlio
Amadori Dino
Zoli Wainer
author_sort Vannini Ivan
title Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
title_short Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
title_full Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
title_fullStr Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
title_full_unstemmed Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
title_sort study of molecular mechanisms of pro-apoptotic activity of ncx 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2007-10-01
description <p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties. In the present study, we investigated the mechanisms underlying the cytotoxicity of NCX 4040, a novel NO-aspirin with promising antineoplastic action, in <it>in vitro </it>human colon cancer models.</p> <p>Methods</p> <p>The effect on tumor growth was evaluated in four human colon cancer cell lines (LoVo, LRWZ, WiDr and LoVo Dx) by sulforhodamine B assay, oxidative stress by immunohistochemistry, apoptosis by laddering assay, mitochondrial membrane potential (ΔΨ<sub>m</sub>) by flow cytometry, and apoptosis- and chemoresistance-related markers by western-blot and real-time method, respectively. Prostaglandin E<sub>2 </sub>levels were determined by ELISA.</p> <p>Results</p> <p>NCX 4040 produced a higher cytotoxic effect in all the cell lines than that produced by other NO donors tested. In particular, in LoVo and LRWZ cells, NCX 4040 induced a cytocidal effect and apoptosis through p53 and NAG-1 expression, an early ΔΨ<sub>m </sub>collapse, and a sequential release of cytoplasmatic cytochrome c and caspase -9 and -3 active forms. 8-hydroxyguanine lesions, indicative of oxidative stress, were also observed. Conversely, in WiDr line, the drug caused a cytocidal effect, albeit not through apoptosis, and a concomitant increase in COX-2 activity. In LoVo Dx line, characterized by high levels drug resistance and DNA repair-related markers, only a cytostatic effect was observed, again in concomitance with the increase in COX-2 enzyme activity.</p> <p>Conclusion</p> <p>This study highlights the multiplicity of mechanisms involved in sensitivity or resistance to NCX 4040 and could provide useful indications for tailored therapy by identifying potentially drug-responsive tumors.</p>
url http://www.translational-medicine.com/content/5/1/52
work_keys_str_mv AT vanniniivan studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT medrilaura studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT fabbrifrancesco studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT ulivipaola studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT rosettimarco studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT teseianna studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT bollamanlio studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT amadoridino studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
AT zoliwainer studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines
_version_ 1716802132887207936